Evaluation of Salivary Flow and Buffer Capacity Associated to Aged People's Oral Health

March 31, 2008 updated by: Academia Cearense de Odontologia
The purpose of this study is to identify the relation of the salivary flow and the buffer capacity of the saliva with medicine, buccal discomfort and auto-related illnesses in aged people.

Study Overview

Status

Completed

Conditions

Detailed Description

Study clinical of prevalence. 68 aged, average 70.4 years, SD ± 7.27 represented institution's residents of long permanence. Questionnaire was applied, organizing the data for Software SPSS version 15. The test qui-square of Pearson was used, level of significance 5% and reliable interval 95%. 80% presented pH normal. The salivary Flow: 32.3% very low, 41.2% reduced and 25.5% normal. 30.9% mentioned dry mouth, 22.1% tasting's problems, 17.6% dysphagia and 14.7% burning mouth. Main systemic illnesses: 48.5% declared cardiovascular problems, 17.6% diabetes and 16.2% osteoporosis. 76.5% used medicine. There was a significance statistic between medicine taking and dry mouth (p=0.013), buffer capacity and burning mouth (p=0.019), salivary flow and medicine taking (p=0.048). The low salivary flow and the buffer capacity of the saliva influence in the aged people's health condition, as the drugs influence the results.

Study Type

Observational

Enrollment (Actual)

68

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Brazil
    • Ceara
      • Fortaleza, Ceara, Brazil
        • Instituição de Longa Permanência Lar Torres de Melo

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

58 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

68 aged, average 70.4 years, SD ± 7.27 represented institution's residents of long permanence.

Description

Inclusion Criteria:

  • aged people with 60 years old or more,
  • ills or not,
  • able to realize tests
  • people who want to participate of research

Exclusion Criteria:

  • people less 60 years old

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Academia Cearense de Odontologia

Investigators

  • Principal Investigator: Maria VL Saintrain, doutor, Universidade de Fortaleza

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2006

Study Completion (Actual)

August 1, 2007

Study Registration Dates

First Submitted

March 31, 2008

First Submitted That Met QC Criteria

March 31, 2008

First Posted (Estimate)

April 2, 2008

Study Record Updates

Last Update Posted (Estimate)

April 2, 2008

Last Update Submitted That Met QC Criteria

March 31, 2008

Last Verified

March 1, 2008

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • renatago

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Oral Health

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Myanmar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe